GLUCLIPSE Trademark

Trademark Overview

On Wednesday, September 1, 2010, a trademark application was filed for GLUCLIPSE with the United States Patent and Trademark Office. The USPTO has given the GLUCLIPSE trademark a serial number of 85120470. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 1, 2014. This trademark is owned by Bristol-Myers Squibb Company. The GLUCLIPSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system and immune system related diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals and anti-virals
gluclipse

General Information

Serial Number85120470
Word MarkGLUCLIPSE
Filing DateWednesday, September 1, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 1, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system and immune system related diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals and anti-virals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 6, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameASTRAZENECA AB
Party Type21 - New Owner After Publication
Legal Entity Type11 - Company
AddressSODERTALJE SE-151 85
SE
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Wednesday, October 8, 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 2, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 1, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 19, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 18, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 18, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 31, 2014EXTENSION 5 GRANTED
Friday, January 24, 2014EXTENSION 5 FILED
Friday, January 24, 2014TEAS EXTENSION RECEIVED
Saturday, July 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 5, 2013EXTENSION 4 GRANTED
Monday, July 1, 2013EXTENSION 4 FILED
Monday, July 1, 2013TEAS EXTENSION RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, January 15, 2013EXTENSION 3 GRANTED
Thursday, January 10, 2013EXTENSION 3 FILED
Thursday, January 10, 2013TEAS EXTENSION RECEIVED
Saturday, June 30, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, June 29, 2012EXTENSION 2 GRANTED
Tuesday, June 26, 2012EXTENSION 2 FILED
Tuesday, June 26, 2012TEAS EXTENSION RECEIVED
Thursday, January 26, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, January 25, 2012EXTENSION 1 GRANTED
Thursday, December 22, 2011EXTENSION 1 FILED
Wednesday, January 25, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 22, 2011TEAS EXTENSION RECEIVED
Tuesday, July 26, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2011PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2011NOTICE OF PUBLICATION
Friday, April 22, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 22, 2011ASSIGNED TO LIE
Tuesday, April 19, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 7, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 7, 2011EXAMINERS AMENDMENT MAILED
Wednesday, April 6, 2011EXAMINER'S AMENDMENT ENTERED
Wednesday, April 6, 2011EXAMINERS AMENDMENT -WRITTEN
Monday, April 4, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 4, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 4, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 30, 2010PRIORITY ACTION MAILED
Tuesday, November 30, 2010PRIORITY ACTION WRITTEN
Monday, November 29, 2010ASSIGNED TO EXAMINER
Monday, September 6, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 4, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

gluclipse diseases system pharmaceutical disorders anti preparations human immune solid auto